A 28-year-old woman from Mumbai presents with a 6-month history of arthralgia in her hands and knees, morning stiffness lasting 2 hours, and a photosensitive malar rash. She reports recurrent oral ulcers and has noticed hair loss over the past 3 months. Laboratory investigations show: ANA 1:640 (homogeneous pattern), anti-dsDNA antibodies positive (180 IU/mL), anti-Smith antibodies positive, complement C3 level 45 mg/dL (normal 90–180), and urinalysis shows 2+ proteinuria with RBC casts. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Systemic Lupus Erythematosus with Lupus Nephritis ### Key Clinical Features Present **Key Point:** This patient meets ≥4 of the 2019 EULAR/ACR SLE classification criteria: 1. Malar rash (photosensitive) 2. Oral ulcers 3. Arthralgia/arthritis (hands, knees) 4. Alopecia 5. Serology: ANA positive, anti-dsDNA positive, anti-Smith positive 6. Low complement (C3 45 mg/dL) 7. Renal involvement (proteinuria + RBC casts = active glomerulonephritis) ### Serological Signature of SLE | Marker | Significance | Patient's Status | |--------|--------------|------------------| | **ANA (homogeneous)** | Present in >95% of SLE; high sensitivity | Positive 1:640 | | **Anti-dsDNA** | Highly specific for SLE; associated with nephritis | Positive (180 IU/mL) | | **Anti-Smith (Sm)** | Highly specific for SLE; never seen in other diseases | Positive | | **Low C3/C4** | Indicates active disease, lupus nephritis | C3 = 45 (↓) | **High-Yield:** The combination of **anti-dsDNA + anti-Sm + low complement + active urinary findings** is pathognomonic for SLE with active glomerulonephritis. ### Renal Involvement (Lupus Nephritis) **Clinical Pearl:** RBC casts + proteinuria + low complement indicates **proliferative lupus nephritis** (WHO Class III or IV). This requires immediate immunosuppressive therapy to prevent progression to ESRD. ### Pathophysiology 1. **Immune complex deposition:** Anti-dsDNA antibodies form circulating immune complexes that deposit in glomeruli 2. **Complement activation:** Leads to C3/C4 consumption (explaining low levels) 3. **Glomerular injury:** Type III hypersensitivity reaction → inflammation, RBC leakage, proteinuria 4. **Systemic manifestations:** ANA-driven B and T cell activation → multi-organ involvement ```mermaid flowchart TD A[Genetic predisposition + Environmental trigger]:::outcome --> B[Loss of immune tolerance] B --> C[Autoreactive B and T cells activated] C --> D[Production of anti-dsDNA, anti-Sm antibodies] D --> E[Circulating immune complex formation] E --> F{Deposition site?}:::decision F -->|Glomeruli| G[Lupus nephritis]:::urgent F -->|Skin| H[Malar rash, photosensitivity]:::outcome F -->|Joints| I[Arthralgia/arthritis]:::outcome G --> J[Complement activation + inflammation] J --> K[RBC casts, proteinuria, renal dysfunction]:::outcome ``` **Mnemonic: SOAP BRAIN MD** (SLE classification criteria) - **S**erology (ANA, anti-dsDNA, anti-Sm, low complement) - **O**ral ulcers - **A**rthritis - **P**hotosensitivity - **B**lood (cytopenias) - **R**enal (casts, proteinuria) - **A**NA - **I**mmunologic (anti-dsDNA, anti-Sm, antiphospholipid) - **N**eurologic - **M**alar rash - **D**iscoid rash ### Why This Is NOT Drug-Induced Lupus **Warning:** Drug-induced lupus (DIL) typically presents with: - Anti-histone antibodies (NOT anti-dsDNA or anti-Sm) - Absence of renal involvement - Absence of CNS/hematologic manifestations - Reversible upon drug withdrawal This patient has anti-dsDNA and anti-Sm (specific for idiopathic SLE) plus active nephritis—diagnostic of true SLE.